Keyphrases
Healthcare Utilization
100%
Clinical Characteristics
100%
Clinical Healthcare
100%
Idiopathic multicentric Castleman Disease (iMCD)
100%
AIDS/HIV
66%
Virus Status
50%
Drug Therapy
33%
Lymphoproliferative Disorders
33%
United States
16%
Medical Records
16%
Healthcare Professionals
16%
Clinical Features
16%
Disease Diagnosis
16%
Conventional Chemotherapy
16%
Laboratory Testing
16%
Pharmacotherapy
16%
Histology
16%
Treatment Decisions
16%
Virus Diseases
16%
First Year
16%
Rituximab
16%
Demographic Characteristics
16%
Clinical Criteria
16%
Corticosteroids
16%
Biochemical Characteristics
16%
Kruskal-Wallis Test
16%
1-year Survival
16%
Human Immunodeficiency Virus Infection
16%
Treatment Facilities
16%
2-year Survival
16%
Fisher
16%
Hyaline Vascular Type
16%
Disease Subtypes
16%
Plasmacytic
16%
Human Immunodeficiency Virus Negative
16%
Medical Utilization
16%
Therapy Utilization
16%
Feature Utilization
16%
Heterogeneous Treatment
16%
Nursing and Health Professions
Health Care Utilization
100%
Angiofollicular Lymph Node Hyperplasia
100%
Human Immunodeficiency Virus
83%
Drug Therapy
50%
Lymphoproliferative Disease
33%
Medical Record
16%
Health Care Personnel
16%
Clinical Feature
16%
Human Immunodeficiency Virus Infection
16%
Laboratory Test
16%
Rituximab
16%
Kruskal Wallis Test
16%
Treatment Centre
16%
Hyalin
16%
Diseases
16%
Medicine and Dentistry
Angiofollicular Lymph Node Hyperplasia
100%
Human Immunodeficiency Virus
83%
Drug Therapy
50%
Lymphoproliferative Disease
33%
Medical Record
16%
Identified Patient
16%
Laboratory Test
16%
Clinical Feature
16%
Rituximab
16%
Human Immunodeficiency Virus Infection
16%
Kruskal Wallis Test
16%
Diseases
16%
Pharmacology, Toxicology and Pharmaceutical Science
Angiofollicular Lymph Node Hyperplasia
100%
HIV
83%
Pharmacotherapy
50%
Lymphoproliferative Disease
33%
Chemotherapy
16%
Rituximab
16%
Clinical Feature
16%
Human Immunodeficiency Virus Infection
16%
Hyalin
16%
Diseases
16%
Immunology and Microbiology
Castleman's Disease
100%
Human Immunodeficiency Virus
83%
Drug Therapy
50%
Medical Record
16%
Human Immunodeficiency Virus Infection
16%
Laboratory Test
16%
Rituximab
16%
Lymphoproliferative Disorders
16%